Onderzoeker
Denis Schallier
- Trefwoorden:Geneeskunde
- Disciplines:Sociale wetenschappen
Affiliaties
- Laboratorium Moleculaire Oncologie (Onderzoeksgroep)
Lid
Vanaf1 jan 2010 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 jan 2014 → 31 dec 2015 - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 jan 2014 → 23 jul 2015 - Medische Oncologie (Departement)
Lid
Vanaf1 jun 2010 → 30 sep 2021 - Immunologie en Microbiologie (Departement)
Lid
Vanaf1 okt 2009 → 31 dec 2013 - Immunologie en Microbiologie (Departement)
Lid
Vanaf1 okt 2009 → 31 dec 2013
Publicaties
1 - 10 van 49
- Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)(2023)
Auteurs: Odrade Gondry, Catarina Xavier, Laurens Raes, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Karine Breckpot, Quentin Lecocq, Lore Decoster, Christel Fontaine, et al.
Pagina's: 1378-1384 - Antitumor Activity of Cabozantinib in Metastatic Adult Ewing Sarcoma(2020)
Auteurs: Denis Schallier, Pierre Lesfevre, Hendrik Everaert
Pagina's: 2265-2269 - Treatment of older patients with advanced non-small cell lung cancer(2019)
Auteurs: Lore Decoster, Denis Schallier
Pagina's: 528-533 - Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer.(2019)
Auteurs: Sofie Joris, Christel Fontaine, Lore Decoster, Leen Vanacker, Denis Schallier, Jacques De Grève
Pagina's: 663-666 - Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer(2018)
Auteurs: Lore Decoster, Christel Fontaine, Leen Vanacker, Denis Schallier, Jacques De Grève
Pagina's: 695-697 - The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal Cancers.(2018)
Auteurs: Yori Gidron, Denis Schallier, Jean-Luc Van Laethem, Raphaël Maréchal
Pagina's: 4874193 - Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?(2017)
Auteurs: Charles Van Praet, Sylvie Rottey, Fransien Van Hende, Gino Pelgrims, Wim Demey, Filip Van Aelst, Wim Wynendaele, Thierry Gil, Peter Schatteman, Bertrand Filleul, et al.
Pagina's: 502-508 - Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer(2017)
Auteurs: Lore Decoster, C Kenis, Denis Schallier, J. Vansteenkiste, K Nackaerts, Leen Vanacker, N Vandewalle, J. Flamaing, J.p. Lobelle, K. Milisen, et al.
Pagina's: 619-626 - Prostatic Leiomyoma(2016)
Auteurs: Annelies Ringoir, Bernard Rappe, Karl Dhaene, Denis Schallier
Pagina's: 45-47 - Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program(2016)
Auteurs: Charles Van Praet, Sylvie Rottey, Fransien Van Hende, Gino Pelgrims, Wim Demey, Filip Van Aelst, Wim Wynendaele, Thierry Gil, Peter Schatteman, Bertrand Filleul, et al.
Pagina's: 254.e7-254.e13